Our highly scalable platform captures and isolates highly metastatic cancer cells with benchmark results comparable to the common mouse models that will help pharmaceutical companies, research centres and universities to cut research time and cost significantly. MoC surpasses the limitations of mice to accurately reflect human diseases and predict clinical efficacy more accurately.